世界のがん治療における新規ドラッグデリバリーシステム市場

【英語タイトル】Novel Drug Delivery Systems In Cancer Therapy Market

Future Market Insightsが出版した調査資料(FMI22DV023)・商品コード:FMI22DV023
・発行会社(調査会社):Future Market Insights
・発行日:2022年6月7日
・ページ数:309
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single Price(1名様閲覧用)USD5,000 ⇒換算¥740,000見積依頼/購入/質問フォーム
Site Licence(同一拠点内共有可)USD7,500 ⇒換算¥1,110,000見積依頼/購入/質問フォーム
Enterprisewide(複数拠点内共有可)USD10,000 ⇒換算¥1,480,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Future Market Insights社の本調査レポートは、世界のがん治療における新規ドラッグデリバリーシステム市場を調査対象とし、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景・基礎データポイント、主な成功要因、需要分析・予測、市場規模分析・予測、製品別(ナノ粒子、塞栓用粒子)分析、地域別状況(北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ)分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成でまとめております。なお、参入企業情報として、Teva Pharmaceutical Industries Ltd.、Johnson & Johnson Services, Inc.、Galen Limited、Merrimack Pharmaceuticals, Inc、Samyang Biopharmaceuticals Corp., Inc.などが含まれております。
・エグゼクティブサマリー
・市場概要
・市場リスク・動向分析
・市場背景・基礎データポイント
・主な成功要因
・世界のがん治療における新規ドラッグデリバリーシステム市場規模:製品別
- ナノ粒子の市場規模
- 塞栓用粒子の市場規模
・世界のがん治療における新規ドラッグデリバリーシステム市場規模:地域別
- 北米のがん治療における新規ドラッグデリバリーシステム市場規模
- 中南米のがん治療における新規ドラッグデリバリーシステム市場規模
- ヨーロッパのがん治療における新規ドラッグデリバリーシステム市場規模
- アジア太平洋のがん治療における新規ドラッグデリバリーシステム市場規模
- 中東/アフリカのがん治療における新規ドラッグデリバリーシステム市場規模
・市場構造分析
・競争分析
・仮定
・調査手法

Novel Drug Delivery Systems In Cancer Therapy Market: Global Industry Analysis 2015-2021 and Opportunity Assessment 2022-2032

A recent market study published by FMI on Novel Drug Delivery Systems In Cancer Therapy offers a global industry analysis for 2015-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation
The global Novel Drug Delivery Systems In Cancer Therapy Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers

By Product Type
• Nanoparticles
• Embolization Particles

By Region
• North America
• Latin America
• Asia Pacific
• Middle East and Africa
• Europe

Report Chapters
Executive Summary
The executive summary of the Novel Drug Delivery Systems In Cancer Therapy Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Novel Drug Delivery Systems In Cancer Therapy.

Chapter 01 – Market Overview
Readers can find the detailed segmentation and definition of the Novel Drug Delivery Systems In Cancer Therapy Market in this chapter, which will help to understand basic information about Novel Drug Delivery Systems In Cancer Therapy. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Novel Drug Delivery Systems In Cancer Therapy Market report.

Chapter 02 – Market Background
This Chapter includes detailed analysis of the product processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The
Chapter also covers forecast factors – relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 – Global Novel Drug Delivery Systems In Cancer Therapy Market Demand Analysis 2015-2021 and Forecast, 2022-2032
The Chapter include historical market value (xx) analysis (2015-2021) and current and future market value (US$ 14.8 billion) and volume (19.6%) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 – Global Novel Drug Delivery Systems In Cancer Therapy Market – Pricing Analysis
Based on By Product Type, the pricing analysis Chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 – Global Novel Drug Delivery Systems In Cancer Therapy Market Analysis 2015-2021 and Forecast 2022-2032, By Product Type
Based on By Product Type, Novel Drug Delivery Systems In Cancer Therapy Market is segmented into Nanoparticles,Embolization Particles.This section also offers market attractiveness analysis based on By Product Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Product Type.

Chapter 06 – Global Novel Drug Delivery Systems In Cancer Therapy Market Analysis 2015-2021 and Forecast 2022-2032, By Region
Based on By Region, Novel Drug Delivery Systems In Cancer Therapy Market is segmented into North America,Latin America,Europe,Middle East & Africa,Asia Pacific. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 7 – North America Novel Drug Delivery Systems In Cancer Therapy Market Analysis 2015-2021 and Forecast 2022-2032
This Chapter includes a detailed analysis of the growth of the Novel Drug Delivery Systems In Cancer Therapy in the North American Region, along with a country-wise assessment that includes the US and Canada. Readers can also find Regional trends, regulations, and market growth based on different segment and countries in the North America Region.

Chapter 8 – Latin America Novel Drug Delivery Systems In Cancer Therapy Market Analysis 2015-2021 and Forecast 2022-2032
This Chapter includes a detailed analysis of the growth of Novel Drug Delivery Systems In Cancer Therapy in the Latin America Region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Novel Drug Delivery Systems In Cancer Therapy Market in the Latin America Region.

Chapter 9 – Europe Novel Drug Delivery Systems In Cancer Therapy Market Analysis 2015-2021 and Forecast 2022-2032
This Chapter includes a detailed analysis of the growth of Novel Drug Delivery Systems In Cancer Therapy in the European Region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Novel Drug Delivery Systems In Cancer Therapy Market in the Regional market.

Chapter 10 – East Asia Novel Drug Delivery Systems In Cancer Therapy Market Analysis 2015-2021 and Forecast 2022-2032
This Chapter includes a detailed analysis of the growth of Novel Drug Delivery Systems In Cancer Therapy in the East Asia Region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Novel Drug Delivery Systems In Cancer Therapy Market in the Regional market.

Chapter 11– South Asia Novel Drug Delivery Systems In Cancer Therapy Market Analysis 2015-2021 and Forecast 2022-2032
This Chapter includes a detailed analysis of the growth of Novel Drug Delivery Systems In Cancer Therapy in the South Asia Region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Novel Drug Delivery Systems In Cancer Therapy Market in the Regional market.

Chapter 12 – Middle East and Africa Novel Drug Delivery Systems In Cancer Therapy Market Analysis 2015-2021 and Forecast 2022-2032
This Chapter includes a detailed analysis of the growth of Novel Drug Delivery Systems In Cancer Therapy in the MEA Region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Novel Drug Delivery Systems In Cancer Therapy Market in the Regional market.

Chapter 13 – Key Countries Novel Drug Delivery Systems In Cancer Therapy Market Analysis 2015–2021 and Forecast 2022–2032
This Chapter offers insights into how the Novel Drug Delivery Systems In Cancer Therapy Market is expected to grow in major countries globally.

Chapter 14 – Market Structure Analysis- Global Assessment
This Chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 15 – Competition Deep Dive (Tentative List)
This Chapter includes company overview, product portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the Teva Pharmaceutical Industries Ltd.,Johnson & Johnson Services, Inc.,Galen Limited,Merrimack Pharmaceuticals, Inc,Samyang Biopharmaceuticals Corp., Inc.

Chapter 16 – Assumptions and Acronyms
This Chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Novel Drug Delivery Systems In Cancer Therapy report.

Chapter 17– Research Methodology
This Chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Novel Drug Delivery Systems In Cancer Therapy Market.

❖ レポートの目次 ❖

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

    4.1. Global Market (US$ Mn)

    4.2. Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors – Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Market Growth

        4.5.3. Adoption Rate, by Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032

        8.3.1. Nanoparticles

            8.3.1.1. Liposomes

            8.3.1.2. Polymers

            8.3.1.3. Micelles

            8.3.1.4. Other nanoparticles

        8.3.2. Embolization particles

            8.3.2.1. PVA particles

            8.3.2.2. Drug-eluting beads

            8.3.2.3. Liquid emboli

            8.3.2.4. Other embolization particles

    8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2015-2021 and Forecast 2022-2032

    10.1. Introduction

    10.2. Pricing Analysis

    10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        10.4.1. By Country

            10.4.1.1. U.S.

            10.4.1.2. Canada

        10.4.2. By Product

    10.5. Market Attractiveness Analysis

        10.5.1. By Country

        10.5.2. By Product

11. Latin America Market Analysis 2015-2021 and Forecast 2022-2032

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        11.4.1. By Country

            11.4.1.1. Brazil

            11.4.1.2. Mexico

            11.4.1.3. Rest of Latin America

        11.4.2. By Product

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Product

12. Europe Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. Germany

            12.4.1.2. France

            12.4.1.3. U.K.

            12.4.1.4. Italy

            12.4.1.5. Benelux

            12.4.1.6. Nordic Countries

            12.4.1.7. Rest of Europe

        12.4.2. By Product

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product

13. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. China

            13.4.1.2. Japan

            13.4.1.3. South Korea

            13.4.1.4. Rest of Asia Pacific

        13.4.2. By Product

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product

14. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. GCC Countries

            14.4.1.2. South Africa

            14.4.1.3. Turkey

            14.4.1.4. Rest of Middle East and Africa

        14.4.2. By Product

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

15. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

        15.1.1. Market Value Proportion Analysis, By Key Countries

        15.1.2. Global Vs. Country Growth Comparison

    15.2. US Market Analysis

        15.2.1. Value Proportion Analysis by Market Taxonomy

        15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.2.2.1. By Product

    15.3. Canada Market Analysis

        15.3.1. Value Proportion Analysis by Market Taxonomy

        15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.3.2.1. By Product

    15.4. Mexico Market Analysis

        15.4.1. Value Proportion Analysis by Market Taxonomy

        15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.4.2.1. By Product

    15.5. Brazil Market Analysis

        15.5.1. Value Proportion Analysis by Market Taxonomy

        15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.5.2.1. By Product

    15.6. Germany Market Analysis

        15.6.1. Value Proportion Analysis by Market Taxonomy

        15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.6.2.1. By Product

    15.7. France Market Analysis

        15.7.1. Value Proportion Analysis by Market Taxonomy

        15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.7.2.1. By Product

    15.8. Italy Market Analysis

        15.8.1. Value Proportion Analysis by Market Taxonomy

        15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.8.2.1. By Product

    15.9. BENELUX Market Analysis

        15.9.1. Value Proportion Analysis by Market Taxonomy

        15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.9.2.1. By Product

    15.10. UK Market Analysis

        15.10.1. Value Proportion Analysis by Market Taxonomy

        15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.10.2.1. By Product

    15.11. Nordic Countries Market Analysis

        15.11.1. Value Proportion Analysis by Market Taxonomy

        15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.11.2.1. By Product

    15.12. China Market Analysis

        15.12.1. Value Proportion Analysis by Market Taxonomy

        15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.12.2.1. By Product

    15.13. Japan Market Analysis

        15.13.1. Value Proportion Analysis by Market Taxonomy

        15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.13.2.1. By Product

    15.14. South Korea Market Analysis

        15.14.1. Value Proportion Analysis by Market Taxonomy

        15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.14.2.1. By Product

    15.15. GCC Countries Market Analysis

        15.15.1. Value Proportion Analysis by Market Taxonomy

        15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.15.2.1. By Product

    15.16. South Africa Market Analysis

        15.16.1. Value Proportion Analysis by Market Taxonomy

        15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.16.2.1. By Product

    15.17. Turkey Market Analysis

        15.17.1. Value Proportion Analysis by Market Taxonomy

        15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            15.17.2.1. By Product

        15.17.3. Competition Landscape and Player Concentration in the Country

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

        16.4.1. By Regional footprint of Players

        16.4.2. Product footprint by Players

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

        17.3.1. Teva Pharmaceutical Industries Ltd.

            17.3.1.1. Overview

            17.3.1.2. Product Portfolio

            17.3.1.3. Sales Footprint

            17.3.1.4. Strategy Overview

        17.3.2. Johnson & Johnson Services, Inc.

            17.3.2.1. Overview

            17.3.2.2. Product Portfolio

            17.3.2.3. Sales Footprint

            17.3.2.4. Strategy Overview

        17.3.3. Galen Limited

            17.3.3.1. Overview

            17.3.3.2. Product Portfolio

            17.3.3.3. Sales Footprint

            17.3.3.4. Strategy Overview

        17.3.4. Merrimack Pharmaceuticals, Inc

            17.3.4.1. Overview

            17.3.4.2. Product Portfolio

            17.3.4.3. Sales Footprint

            17.3.4.4. Strategy Overview

        17.3.5. Takeda Pharmaceutical Company Limited

            17.3.5.1. Overview

            17.3.5.2. Product Portfolio

            17.3.5.3. Sales Footprint

            17.3.5.4. Strategy Overview

        17.3.6. Samyang Biopharmaceuticals Corp., Inc

            17.3.6.1. Overview

            17.3.6.2. Product Portfolio

            17.3.6.3. Sales Footprint

            17.3.6.4. Strategy Overview

        17.3.7. Celgene Corporation

            17.3.7.1. Overview

            17.3.7.2. Product Portfolio

            17.3.7.3. Sales Footprint

            17.3.7.4. Strategy Overview

        17.3.8. Spectrum Pharmaceuticals, Inc.

            17.3.8.1. Overview

            17.3.8.2. Product Portfolio

            17.3.8.3. Sales Footprint

            17.3.8.4. Strategy Overview

        17.3.9. BTG Limited

            17.3.9.1. Overview

            17.3.9.2. Product Portfolio

            17.3.9.3. Sales Footprint

            17.3.9.4. Strategy Overview

18. Assumptions and Acronyms Used

19. Research Methodology



★調査レポート[世界のがん治療における新規ドラッグデリバリーシステム市場] (コード:FMI22DV023)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のがん治療における新規ドラッグデリバリーシステム市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆